Medicskin Holdings Limited provided unaudited consolidated earnings guidance for six months ended 30 September 2022. For the period, the company expects consolidated loss attributable to owners of the Company of approximately HKD 3.3 million for the six months ended 30 September 2022, as compared to a net profit attributable to owners of the Company of approximately HKD 1.8 million for the six months ended 30 September 2021. The Board considers that the aforesaid turning into loss from profit was mainly attributable to: a decline of approximately HKD 6.6 million, or 24.8%, of the revenue of the Group for the six months ended 30 September 2022 as compared to the same period of last year due to the negative impacts brought by the COVID-19 pandemic in Hong Kong and the intense competition in the market; and the effect of unrealised exchange loss arising from translation of bank deposits denominated in Chinese Renminbi of HKD 1.4 million.